Canada Markets close in 3 hrs 50 mins

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6919-0.0140 (-1.98%)
As of 12:09PM EST. Market open.
Full screen
Loading interactive chart...
  • Zacks

    Agile Therapeutics (AGRX) Reports Q3 Loss, Lags Revenue Estimates

    Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 5.26% and -13.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Agile Therapeutics Reports Third Quarter 2021 Financial Results

    Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed Twirla Refill Rates Continue to Grow by 86% in Third Quarter 2021 Company Advances Programs Focused on Increasing Demand for Twirla Management to Host Conference Call Today, Tuesday, November 2, 2021 at 4:30 p.m. EDT PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three mont

  • GlobeNewswire

    Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2, 2021

    Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report third quarter 2021 financial results after the market close on Tuesday, November 2, 2021 as follows: DateTuesday, November 2, 2021Time4:30 p.m. ETWebcast (live and archived)Events & PresentationsDial-in numbers(833) 979-2857 (U.S. toll-free) or (236) 714-2948Conference ID9988403 Investors intereste